Effect of continuous blood purification in treatment of patients with severe acute pancreatitis and multiple organ dysfunction syndrome

Zhang Yong; Zeng WeiZheng; Wang YunXia; Weng Min; Zheng ShuMei; Jiang MingDe

doi:10.3969/j.issn.1001-5256.2016.02.025

Issue 2

Feb. 2016

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2016 > 32(2): 320-323

PDF( 1531 KB)

Effect of continuous blood purification in treatment of patients with severe acute pancreatitis and multiple organ dysfunction syndrome

DOI: 10.3969/j.issn.1001-5256.2016.02.025

Department of Gastroenterology,General Hospital of Chengdu Command Area of Chinese PLA

Received Date: 2015-07-20
Published Date: 2016-02-20

Abstract

Abstract

Objective To observe the effect of continuous blood purification( CBP) on serum inflammatory mediators in patients with severe acute pancreatitis( SAP) and multiple organ dysfunction syndrome( MODS). Methods Sixty- five SAP patients with MODS who were treated in General Hospital of Chengdu Command Area of Chinese PLA from April 2008 to December 2013 were enrolled and divided into two groups. The 33 patients in the control group received comprehensive internal medicine treatment,and the 32 patients in the treatment group received comprehensive internal medicine treatment and CBP. Changes in APACHE II score,MODS score,and the serum levels of tumor necrosis factor α( TNFα),C- reactive protein( CRP),interleukin 6( IL- 6),IL- 18,platelet- activating factor( PAF),and nitric oxide( NO) after treatment were observed. Independent- samples t test was applied for comparison of continuous data between the two groups,and paired t test was applied for before- after comparison within the same group; chi- squared test was applied for comparison of categorical data between the two groups. Results In both groups,APACHE II score,MODS score,and the serum levels of TNFα,CRP,IL- 6,IL- 18,PAF,and NO decreased significantly after treatment( all P < 0. 05),and the treatment group had significantly greater decreases in these values than the control group( all P < 0. 001); the survival rates in the treatment group and the control group were 90. 6%( 29 /32)and 78. 8%( 26 /33),respectively,with no significant difference between the two groups( χ2= 1. 749,P = 0. 186). Conclusion In SAP patients with MODS,CBP can effectively clear the serum inflammatory mediators to block systemic inflammatory response and improve organ function,and,therefore,it is an effective method to treat SAP.
- pancreatitis,
- multiple organ failure,
- hemofiltration,
- treatment outcome

FullText(HTML)

References(13)

References

[1]MALMSTRM ML,HANSEN MB,ANDERSEN AM,et al.Cytokines and organ failure in acute pancreatitis:inflammatory response in acute pancreatitis[J].Pancreas,2012,41(2):271-277.

[2]ZHANG NN,GUO XZ,LI HY,et al.A meta-analysis of blood purification in severe acute pancreatitis in chinese clinical trials[J].Trauma Crit Care Med,2014,2(1):42-47.(in Chinese)张宁宁,郭晓钟,李宏宇,等.血液净化治疗急性重症胰腺炎疗效Meta分析[J].创伤与急危重病医学,2014,2(1):42-47.

[3]Pancreatic Disease Group of Digestive Disease Branch of Chinese Association.Recommendation of standardized treatment of internal medicine for severe acute pancreatitis[J].Chin J Dig,2009,29(2):75-78.(in Chinese)中华医学会消化病学分会胰腺病学组.重症急性胰腺炎内科规范治疗建议[J].中华消化杂志,2009,29(2):75-78.

[4]WANG JD,WANG BE.Staging diagnosis and severity score criteria for multiple organ dysfunction syndrome(MODS)[J].Chin Critical Care Med,1995,7(6):346-347.(in Chinese)王今达,王宝恩.多脏器功能失常综合征(MODS)病情分期诊断及严重程度评分标准[J].中国危重病急救医学,1995,7(6):346-347.

[5]LU SY,PAN XZ.Recent progress in understanding the pathogenesis of severe acute pancreatitis[J].World Chin J Dig,2011,19(23):2421-2425.(in Chinese)卢世云,潘秀珍.重症急性胰腺炎发病机制研究现状[J].世界华人消化杂志,2011,19(23):2421-2425.

[6] ZHANG J,NIU J,YANG J.Interleukin-6,interleukin-8 and interleukin-10 in estimating the severity of acute pancreatitis:an updated meta-analysis[J].Hepatogastroenterology,2014,61(129):215-220.

[7]CHEN C,XIA SH,CHEN H,et al.Therapy for acute pancreatitis with platelet-activating factor receptor antagonists[J].World J Gastroenterol,2008,14(30):4735-4738.

[8]XIA SH,HU CX,ZHAO ZL,et al.Significance of platelet activating factor receptor expression in pancreatic tissues of rats with severe acute pancreatitis and effects of BN52021[J].World J Gastroenterol,2007,13(21):2992-2998.

[9]LIANG J,ZHOU Y,WANG Z,et al.Relationship between liver damage and serum levels of IL-8,TNF-αand NO in patients with acute pancreatitis[J].J South Med Univ,2010,30(8):1912-1914.(in Chinese)梁坚,周宇,王壮,等.急性胰腺炎肝损害与血清IL-18、TNF-α、NO的关系[J].南方医科大学学报,2010,30(8):1912-1914.

[10]HEINRICH S,SCHFER M,ROUSSON V,et al.Evidencebased treatment of acute pancreatitis:a look at established paradigms[J].Ann Surg,2006,243(2):154-168.

[11]HE C,ZHANG L,SHI W,et al.Coupled plasma filtration adsorption combined with continuous veno-venous hemofiltration treatment in patients with severe acute pancreatitis[J].J Clin Gastroenterol,2013,47(1):62-68.

[12]CHU LP,ZHOU JJ,YU YF,et al.Clinical effects of pulse highvolume hemofiltration on severe acute pancreatitis complicated with multiple organ dysfunction syndrome[J].Ther Apher Dial,2013,17(1):78-83.

[13]XU J,TIAN X,ZHANG C,et al.Management of abdominal compartment syndrome in severe acute pancreatitis patients with early continuous veno-venous hemofiltration[J].Hepatogastroenterology,2013,60(127):1749-1752.

Relative Articles

[1]	Tingting DU, Hui YAO, Xiaohong CHEN, Jie LUO, Luhong YANG, Lifang FENG, Xiaoqian CHEN, Man HU, Juan LUO. Clinical features of hypopituitarism with nonalcoholic fatty liver disease after sellar tumor surgery in children[J]. Journal of Clinical Hepatology, 2023, 39(6): 1332-1339. doi: 10.3969/j.issn.1001-5256.2023.06.013
[2]	Rong JIANG, Yongxia LI. Value of triglyceride-glucose index combined with obesity index in predicting nonalcoholic fatty liver disease in individuals with obstructive sleep apnea[J]. Journal of Clinical Hepatology, 2023, 39(3): 546-551. doi: 10.3969/j.issn.1001-5256.2023.03.010
[3]	Huawei QIU, Tianfu LIANG, Zhi ZHONG, Xuejiao JIA, Yang JIANG. Trend and prediction of the disease burden of acute hepatitis B in China[J]. Journal of Clinical Hepatology, 2023, 39(11): 2575-2579. doi: 10.3969/j.issn.1001-5256.2023.11.010
[4]	Zhiqiang ZHANG, Wei CHEN, Bo LIU. Value of spleen volume in predicting portal hypertensive gastropathy and its severity in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2023, 39(4): 826-833. doi: 10.3969/j.issn.1001-5256.2023.04.013
[5]	Xing DAI, Ben GAO, Xinxin ZHANG, Yanyan SUN, Wentao JIANG, Jiang LI. Establishment and validation of a risk prediction model for early-stage complications after liver transplantation[J]. Journal of Clinical Hepatology, 2022, 38(2): 402-408. doi: 10.3969/j.issn.1001-5256.2022.02.027
[6]	Dongxu WANG, Nan NAN, Hao BING, Lianjie LIN. Value of triglyceride-glucose index and body mass index in predicting nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus[J]. Journal of Clinical Hepatology, 2022, 38(5): 1064-1068. doi: 10.3969/j.issn.1001-5256.2022.05.017
[7]	Bingqi MA, Huijuan MENG, Wei ZHANG, Xiaofeng DONG, Meng WANG, Jie DOU, Yuning WU, Shiping LI. Prognostic value of several immune and inflammatory indices after curative-intent resection for intrahepatic cholangiocarcinoma[J]. Journal of Clinical Hepatology, 2022, 38(9): 2061-2066. doi: 10.3969/j.issn.1001-5256.2022.09.021
[8]	Yiping LIU, Xinping LI, Lei CHEN, Jinju XIA, Kairong SONG, Ningyang JIA, Wanmin LIU. Accurate imaging diagnosis and recurrence prediction of hepatocellular carcinoma based on artificial intelligence[J]. Journal of Clinical Hepatology, 2022, 38(3): 521-527. doi: 10.3969/j.issn.1001-5256.2022.03.006
[9]	Guoxu FANG, Qinghua ZHANG, Yongying HUANG, Jianmin WANG, Jingfeng LIU. Application of bioinformatics in predicting the risk of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2022, 38(1): 15-19. doi: 10.3969/j.issn.1001-5256.2022.01.002
[10]	Shaojie DUAN, Zunjing LIU, Jialiang CHEN, Shukun YAO. Value of lipid accumulation product and visceral fat index in predicting nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2022, 38(1): 129-134. doi: 10.3969/j.issn.1001-5256.2022.01.020
[11]	Wang ZheXuan, Wang EnXin, Xia DongDong, Bai Wei, Wang QiuHe, Yuan Jie, Li XiaoMei, Niu Jing, Guo WenGang, Li Kai, Yin ZhanXin, Han GuoHong. Value of Child-Pugh score versus albumin-bilirubin grade in predicting the prognosis of unresectable hepatocellular carcinoma treated by transarterial chemoembolization[J]. Journal of Clinical Hepatology, 2020, 36(1): 113-117. doi: 10.3969/j.issn.1001-5256.2020.01.025
[12]	Feng Gong, Zhang Yan, Yan QinQin, Liu Jing, Liu ManLing, Fan LiPing, Lin SiCen, He Na, Mi Man. Construction and analysis of a predictive model for progressive liver fibrosis in nonalcoholic fatty liver disease based on LASSO regression[J]. Journal of Clinical Hepatology, 2020, 36(10): 2214-2218. doi: 10.3969/j.issn.1001-5256.2020.10.011
[13]	Chen QinQin, Liang CanCan, Yang LiJun, Meng Qing, Ding YongNian. A clinical analysis of Uygur patients with acute ischemic cerebral infarction complicated by nonalcoholic fatty liver disease in Urumqi, China[J]. Journal of Clinical Hepatology, 2018, 34(6): 1259-1263. doi: 10.3969/j.issn.1001-5256.2018.06.025
[14]	Zhang LiHang, Wang ShanJuan, Lu LunGen, Liu YanLi, Wang YiFei, Xie JinBi. Predictive value of coagulation test parameters for acute upper gastrointestinal bleeding in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2018, 34(10): 2130-2135. doi: 10.3969/j.issn.1001-5256.2018.10.014
[15]	Feng Gong, Han HaiJing, Qi Xue, Mi Man, Tian QiuMei, Niu ChunYan. Establishment of a noninvasive diagnosis equation for nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2018, 34(6): 1264-1267. doi: 10.3969/j.issn.1001-5256.2018.06.026
[16]	Zhang HaiYue, Zhou Pei, Gong ZuoJiong. Predictive value of HBs Ag quantification in pegylated interferon therapy for chronic hepatitis B[J]. Journal of Clinical Hepatology, 2016, 32(5): 977-980. doi: 10.3969/j.issn.1001-5256.2016.05.041
[17]	Wang WenJun, Zhao Yan, Xia DongDong, Wang EnXin, Liu Lei, Han GuoHong. Predictive value of neutrophil-lymphocyte ratio and its dynamic change in patients with hepatocellular carcinoma undergoing transarterial chemoembolization[J]. Journal of Clinical Hepatology, 2016, 32(6): 1139-1144. doi: 10.3969/j.issn.1001-5256.2016.06.024
[18]	Huang ShuiWen, Liu BaoRong, Chen MingSheng, Lin Chun, Zhou Rui, Yang HuiAn, Jiang XiaoYan, Pan Chen, Li DongLiang. Establishment of a predictive model for early virologic response in previously untreated chronic hepatitis B patients treated with telbivudine[J]. Journal of Clinical Hepatology, 2016, 32(7): 1287-1291. doi: 10.3969/j.issn.1001-5256.2016.07.014
[19]	Zhang ZhiQiao, Wang GongSui, Kang KaiFu, Wu GuoBiao, Wang Peng. Analysis of high-risk groups and predictive factors for hepatic steatosis in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2015, 31(7): 1123-1125. doi: 10.3969/j.issn.1001-5256.2015.07.030
[20]	Xie YanDi, Feng Bo, Gao Yan, Wei Lai. Predictive factors for mortality in patients with alcoholic cirrhosis[J]. Journal of Clinical Hepatology, 2013, 29(11): 852-857. doi: 10.3969/j.issn.1001-5256.2013.10.013

Supplements(0)

Cited By

Cited by

Periodical cited type(4)

1.	郭新华，王佳慧，段雪琳，彭岳，赵铁建，郑洋，赵斌. 金属离子代谢：慢性肝病中医药防治新思路. 临床肝胆病杂志. 2024(07): 1498-1504 . 本站查看
2.	董昌君，张先林. 铜死亡在肝细胞癌发病机制中的研究进展. 中国普通外科杂志. 2024(07): 1172-1179 .
3.	刘诗卉，李冬冬，张宏坤，刘传苗，吴执竞，赵文. 细胞死亡在NAFLD发生发展中的研究进展. 齐齐哈尔医学院学报. 2024(16): 1578-1582 .
4.	朱明强，谢星，廖启成，何晓，丁佑铭，王小华. 铜死亡的发生机制及在肝脏疾病中的作用. 临床肝胆病杂志. 2024(11): 2332-2337 . 本站查看

Other cited types(1)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (2408) PDF downloads(442)

Effect of continuous blood purification in treatment of patients with severe acute pancreatitis and multiple organ dysfunction syndrome

DOI: 10.3969/j.issn.1001-5256.2016.02.025